Advertisement

Analytical and Bioanalytical Chemistry

, Volume 407, Issue 11, pp 3137–3146 | Cite as

Development of C-reactive protein certified reference material NMIJ CRM 6201-b: optimization of a hydrolysis process to improve the accuracy of amino acid analysis

  • Megumi KatoEmail author
  • Tomoya Kinumi
  • Mariko Yoshioka
  • Mari Goto
  • Shin-ichiro Fujii
  • Akiko Takatsu
Research Paper
Part of the following topical collections:
  1. Reference Materials for Chemical Analysis

Abstract

To standardize C-reactive protein (CRP) assays, the National Metrology Institute of Japan (NMIJ) has developed a C-reactive protein solution certified reference material, CRM 6201-b, which is intended for use as a primary reference material to enable the SI-traceable measurement of CRP. This study describes the development process of CRM 6201-b. As a candidate material of the CRM, recombinant human CRP solution was selected because of its higher purity and homogeneity than the purified material from human serum. Gel filtration chromatography was used to examine the homogeneity and stability of the present CRM. The total protein concentration of CRP in the present CRM was determined by amino acid analysis coupled to isotope-dilution mass spectrometry (IDMS-AAA). To improve the accuracy of IDMS-AAA, we optimized the hydrolysis process by examining the effect of parameters such as the volume of protein samples taken for hydrolysis, the procedure of sample preparation prior to the hydrolysis, hydrolysis temperature, and hydrolysis time. Under optimized conditions, we conducted two independent approaches in which the following independent hydrolysis and liquid chromatography-isotope dilution mass spectrometry (LC-IDMS) were combined: one was vapor-phase acid hydrolysis (130 °C, 24 h) and hydrophilic interaction liquid chromatography-mass spectrometry (HILIC-MS) method, and the other was microwave-assisted liquid-phase acid hydrolysis (150 °C, 3 h) and pre-column derivatization liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The quantitative values of the two different amino acid analyses were in agreement within their uncertainties. The certified value was the weighted mean of the results of the two methods. Uncertainties from the value-assignment method, between-method variance, homogeneity, long-term stability, and short-term stability were taken into account in evaluating the uncertainty for a certified value. The certified value and the expanded uncertainty (k = 2) of CRM 6201-b are (40.0 ± 1.6) μmol kg–1.

Keywords

C-reactive protein Certified reference material Amino acid analysis Isotope dilution mass spectrometry Hydrolysis optimization 

Supplementary material

216_2014_8190_MOESM1_ESM.pdf (185 kb)
ESM 1 (PDF 184 kb)

References

  1. 1.
    Roux KH, Kilpatrick JM, Volanakis JE, Kearney JF (1983) Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy. J Immunol 131:2411–2415Google Scholar
  2. 2.
    Shrive AK, Cheetham GMT, Holden D, Myles DAA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, Greenhough TJ (1996) Three-dimensional structure of human C-reactive protein. Nat Struct Biol 3:346–354CrossRefGoogle Scholar
  3. 3.
    Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812CrossRefGoogle Scholar
  4. 4.
    Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–411Google Scholar
  5. 5.
    Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199–204CrossRefGoogle Scholar
  6. 6.
    Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K (2002) C-reactive protein predicts death in patients with previous premature myocardial infarction—a 10 year follow-up study. Atherosclerosis 160:433–440CrossRefGoogle Scholar
  7. 7.
    Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843CrossRefGoogle Scholar
  8. 8.
    Kushner I (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 389:39–48CrossRefGoogle Scholar
  9. 9.
    Kushner I (2002) C-reactive protein and atherosclerosis. Science 297:520–521CrossRefGoogle Scholar
  10. 10.
    Kimberly MM, Vesper HW, Caudill SP, Cooper GR, Rifai N, Dati F, Myers GL (2003) Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. Clin Chem 49:611–616CrossRefGoogle Scholar
  11. 11.
    Tanaka T, Horio T, Matuo Y (2002) Secretory production of recombinant human C-reactive protein in Escherichia Coli, capable of binding with phosphorylcholine, and its characterization. BBRC 295:163–166Google Scholar
  12. 12.
    Rzychon M, Zegers I, Schimmel H (2010) Analysis of the physicochemical state of C-reactive protein in different preparations including two certified reference materials. Clin Chem 56:1475–1482CrossRefGoogle Scholar
  13. 13.
    Burkitt W, Pritchard C, Arsene C, Henrion A, Bunk D, O'Connor G (2008) Toward Systeme International d’Unite-traceable protein quantification: from amino acids to proteins. Anal Biochem 376:242–251CrossRefGoogle Scholar
  14. 14.
    Kato M, Kato H, Eyama S, Takatsu A (2009) Application of amino acid analysis using hydrophilic interaction liquid chromatography coupled with isotope dilution mass spectrometry for peptide and protein quantification. J Chromatogr B 877:3059–3064CrossRefGoogle Scholar
  15. 15.
    Kinumi T, Ichikawa R, Arimoto H, Takatsu A (2010) Traceable amino acid analyses of proteins and peptides by isotope-dilution mass spectrometry using precolumn derivatization reagent. Anal Sci 26:1007–1010CrossRefGoogle Scholar
  16. 16.
    Jeong J, Lim H, Kim S, Ku H, Oh K, Park S (2011) Quantification of human growth hormone by amino acid composition analysis using isotope dilution liquid-chromatography tandem mass spectrometry. J Chromatogr A 1218:6596–6602CrossRefGoogle Scholar
  17. 17.
    Munoz A, Kral R, Schimmel H (2011) Quantification of protein calibrants by amino acid analysis using isotope dilution mass spectrometry. Anal Biochem 408:124–131CrossRefGoogle Scholar
  18. 18.
    Wu L, Yang B, Bi J, Wang J (2011) Development of bovine serum albumin certified reference. Anal Bioanal Chem 400:3443–3449CrossRefGoogle Scholar
  19. 19.
    Pritchard C, Torma F, Hopley C, Quaglia M, O'Connor G (2011) Investigating microwave hydrolysis for the traceable quantification of peptide standards using gas chromatography-mass spectrometry. Anal Biochem 412:40–46CrossRefGoogle Scholar
  20. 20.
    Kinumi T, Goto M, Eyama S, Kato M, Kasama T, Takatsu A (2012) Development of SI-traceable C-peptide certified reference material NMIJ CRM 6901-a using isotope-dilution mass spectrometry-based amino acid analyses. Anal Bioanal Chem 404:13–21CrossRefGoogle Scholar
  21. 21.
    Eurachem guide (2012) Quantifying uncertainty in analytical measurements. LGC, TeddingtonGoogle Scholar
  22. 22.
    International Organization for Standardization Guide 35 (2006) Reference materials-general and statistical principles for certification, 3rd edn. ISO, GenovaGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Megumi Kato
    • 1
    Email author
  • Tomoya Kinumi
    • 1
  • Mariko Yoshioka
    • 1
  • Mari Goto
    • 1
  • Shin-ichiro Fujii
    • 1
  • Akiko Takatsu
    • 1
  1. 1.Organic Analytical Chemistry Division, Bio-Medical Standards SectionNational Metrology Institute of Japan, National Institute of Advanced Industrial Science and TechnologyTsukubaJapan

Personalised recommendations